Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
C3.ai, Inc. stock logo
AI
C3.ai
$21.99
-0.1%
$21.63
$17.03
$45.08
$2.92B2.014.43 million shs1.82 million shs
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$45.61
0.0%
$41.80
$17.86
$58.40
$3.63B-0.18873,650 shs697,216 shs
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
$6.38
+1.2%
$6.23
$4.66
$10.72
$5.02B2.3512.57 million shs7.42 million shs
Meta Platforms, Inc. stock logo
META
Meta Platforms
$579.35
+5.5%
$578.42
$427.11
$740.91
$1.47T1.2814.43 million shs26.20 million shs
Tesla, Inc. stock logo
TSLA
Tesla
$283.84
+0.6%
$260.13
$167.41
$488.54
$914.21B2.5895.61 million shs83.03 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
C3.ai, Inc. stock logo
AI
C3.ai
-2.22%+7.95%+4.30%-31.40%-2.31%
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
+5.97%+15.04%+12.67%-17.61%+129.31%
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
-3.81%+2.27%+4.38%-23.56%+25.07%
Meta Platforms, Inc. stock logo
META
Meta Platforms
-0.98%+5.42%-4.75%-20.09%+27.62%
Tesla, Inc. stock logo
TSLA
Tesla
-3.38%+12.38%+8.87%-29.51%+53.95%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
C3.ai, Inc. stock logo
AI
C3.ai
4.1212 of 5 stars
4.12.00.03.22.12.50.6
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
3.7973 of 5 stars
3.51.00.04.73.41.70.0
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
2.6045 of 5 stars
4.31.00.00.02.03.30.0
Meta Platforms, Inc. stock logo
META
Meta Platforms
4.0332 of 5 stars
3.43.01.70.03.23.31.9
Tesla, Inc. stock logo
TSLA
Tesla
4.1866 of 5 stars
2.23.00.03.51.85.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
C3.ai, Inc. stock logo
AI
C3.ai
2.14
Hold$29.5834.51% Upside
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
3.00
Buy$76.2967.27% Upside
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
2.50
Moderate Buy$8.5834.64% Upside
Meta Platforms, Inc. stock logo
META
Meta Platforms
2.87
Moderate Buy$688.6318.86% Upside
Tesla, Inc. stock logo
TSLA
Tesla
2.34
Hold$287.461.27% Upside

Current Analyst Ratings Breakdown

Latest AKRO, META, AI, TSLA, and JOBY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$740.00 ➝ $740.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$624.00 ➝ $676.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$705.00 ➝ $640.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$752.00 ➝ $664.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$725.00 ➝ $700.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetPositive ➝ Positive$800.00 ➝ $700.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$675.00 ➝ $725.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$650.00 ➝ $683.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$580.00 ➝ $620.00
5/1/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$685.00 ➝ $690.00
5/1/2025
Tesla, Inc. stock logo
TSLA
Tesla
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$350.00 ➝ $350.00
(Data available from 5/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
C3.ai, Inc. stock logo
AI
C3.ai
$366.92M7.96N/AN/A$7.06 per share3.12
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/A$9.61 per shareN/A
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
$136K36,928.92N/AN/A$1.48 per share4.31
Meta Platforms, Inc. stock logo
META
Meta Platforms
$164.50B8.92$25.62 per share22.61$72.08 per share8.04
Tesla, Inc. stock logo
TSLA
Tesla
$95.72B9.55$3.10 per share91.50$22.89 per share12.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
C3.ai, Inc. stock logo
AI
C3.ai
-$279.70M-$2.23N/AN/AN/A-79.17%-31.31%-26.09%5/27/2025 (Estimated)
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
-$151.76M-$3.75N/AN/AN/AN/A-32.46%-29.83%5/9/2025 (Estimated)
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
-$513.05M-$0.87N/AN/AN/A-42,844.57%-51.76%-42.62%5/6/2025 (Estimated)
Meta Platforms, Inc. stock logo
META
Meta Platforms
$62.36B$23.9224.2019.181.4237.91%38.17%25.31%N/A
Tesla, Inc. stock logo
TSLA
Tesla
$7.13B$1.82139.1383.735.867.26%10.31%6.15%N/A

Latest AKRO, META, AI, TSLA, and JOBY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
-$1.00N/AN/AN/AN/AN/A
5/6/2025Q1 2025
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
-$0.18N/AN/AN/A$0.54 millionN/A
4/30/2025Q1 2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
$5.33$6.43+$1.10$6.43$41.45 billion$42.31 billion
4/22/2025Q1 2025
Tesla, Inc. stock logo
TSLA
Tesla
$0.53$0.27-$0.26$0.12$22.93 billion$19.34 billion
2/28/2025Q4 2024
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
-$0.98-$0.99-$0.01-$0.99N/AN/A
2/26/2025Q3 2025
C3.ai, Inc. stock logo
AI
C3.ai
-$0.25-$0.62-$0.37-$0.62$98.12 million$98.78 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
C3.ai, Inc. stock logo
AI
C3.ai
$0.904.09%N/AN/A N/A
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/AN/A
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
N/AN/AN/AN/AN/A
Meta Platforms, Inc. stock logo
META
Meta Platforms
$2.100.36%N/A8.78%N/A
Tesla, Inc. stock logo
TSLA
Tesla
N/AN/AN/AN/AN/A

Latest AKRO, META, AI, TSLA, and JOBY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/13/2025
Meta Platforms, Inc. stock logo
META
Meta Platforms
quarterly$0.52500.29%3/14/20253/14/20253/26/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
C3.ai, Inc. stock logo
AI
C3.ai
N/A
7.52
7.52
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
0.05
17.25
17.25
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
N/A
16.12
16.12
Meta Platforms, Inc. stock logo
META
Meta Platforms
0.16
2.98
2.98
Tesla, Inc. stock logo
TSLA
Tesla
0.08
2.02
1.61

Institutional Ownership

CompanyInstitutional Ownership
C3.ai, Inc. stock logo
AI
C3.ai
38.96%
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/A
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
52.85%
Meta Platforms, Inc. stock logo
META
Meta Platforms
79.91%
Tesla, Inc. stock logo
TSLA
Tesla
66.20%

Insider Ownership

CompanyInsider Ownership
C3.ai, Inc. stock logo
AI
C3.ai
33.54%
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
7.94%
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
32.40%
Meta Platforms, Inc. stock logo
META
Meta Platforms
13.71%
Tesla, Inc. stock logo
TSLA
Tesla
20.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
C3.ai, Inc. stock logo
AI
C3.ai
700132.74 million85.78 millionOptionable
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
3079.62 million64.26 millionOptionable
Joby Aviation, Inc. stock logo
JOBY
Joby Aviation
1,420787.82 million517.20 millionOptionable
Meta Platforms, Inc. stock logo
META
Meta Platforms
86,5002.53 billion2.19 billionOptionable
Tesla, Inc. stock logo
TSLA
Tesla
127,9003.22 billion2.55 billionOptionable

Recent News About These Companies

Tesla, Inc. stock logo
Energy Stocks To Watch Today - April 30th
No, Tesla is not looking for a new CEO

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
C3.ai stock logo

C3.ai NYSE:AI

$21.99 -0.02 (-0.08%)
As of 03:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

C3.ai, Inc. operates as an enterprise artificial intelligence (AI) software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides C3 AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Ex Machina for analysis-ready data; C3 AI CRM, an industry specific customer relationship management solution; and C3 Generative AI Product Suite that enables to locate, retrieve, and present information. It also offers C3 AI applications, including C3 AI Inventory Optimization, a solution to optimize raw material, in-process, and finished goods inventory levels; C3 AI Supply Network Risk, which identifies emerging inbound and outbound risks across the network; C3 AI Sustainability Suite, which helps to decrease greenhouse gas emission; C3 AI Production Schedule Optimization, a solution for scheduling production; C3 AI Financial Services Suite, which helps to minimize compliance risks; and C3 AI Energy Management solution. In addition, it offers integrated turnkey enterprise AI applications for oil and gas, chemicals, utilities, manufacturing, financial services, defense, intelligence, aerospace, healthcare, and telecommunications market. It has strategic partnerships with Baker Hughes in the areas of oil and gas market; Booz Allen to provide solutions to government, defense, and intelligence sectors; Raytheon; and AWS, Google, and Microsoft. The company was formerly known as C3 IoT, Inc. and changed its name to C3.ai, Inc. in June 2019. C3.ai, Inc. was incorporated in 2009 and is headquartered in Redwood City, California.

Akero Therapeutics stock logo

Akero Therapeutics NASDAQ:AKRO

$45.61 0.00 (-0.01%)
As of 03:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Joby Aviation stock logo

Joby Aviation NYSE:JOBY

$6.38 +0.08 (+1.19%)
As of 03:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Joby Aviation, Inc., a vertically integrated air mobility company, engages in building an electric vertical takeoff and landing aircraft optimized to deliver air transportation as a service. The company intends to build an aerial ridesharing service, as well as developing an application-based platform that will enable consumers to book rides. Joby Aviation, Inc. was founded in 2009 and is headquartered in Santa Cruz, California.

Meta Platforms stock logo

Meta Platforms NASDAQ:META

$579.35 +30.35 (+5.53%)
As of 03:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality headsets, and wearables worldwide. It operates in two segments, Family of Apps and Reality Labs. The Family of Apps segment offers Facebook, which enables people to share, discuss, discover, and connect with interests; Instagram, a community for sharing photos, videos, and private messages, as well as feed, stories, reels, video, live, and shops; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact privately. The Reality Labs segment provides augmented and virtual reality related products comprising consumer hardware, software, and content that help people feel connected, anytime, and anywhere. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California

Tesla stock logo

Tesla NASDAQ:TSLA

$283.84 +1.68 (+0.60%)
As of 03:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.